An evolving decision‑support tool for differentiating Thalassemia Trait from Iron Deficiency Anemia.
Mayir Ellithy Hashim Abdelrahman · MLS in Hematology & Immunohematology
Clinical Context & Rationale
The Diagnostic Challenge: Beta‑Thalassemia Trait (BTT) and Iron Deficiency Anemia (IDA) are the most common causes of microcytic hypochromic anaemia worldwide. Their overlapping CBC patterns often lead to misdiagnosis, unnecessary investigations, or delayed appropriate management.
Limitations of Classical Indices:
Mentzer (MCV/RBC): Population‑specific; poor performance in mild IDA and borderline cases.
England & Fraser (E&F): Hb‑dependent, affected by age, sex, pregnancy, and pre‑analytical factors.
Green & King (G&K): Hb‑based; underperforms in anaemic patients and haemoglobinopathies.
RDWI (MCV×RDW/RBC): Variable performance across ethnic groups; sensitive to RDW fluctuations.
Shine & Lal (S&L): MCH‑dependent; influenced by iron availability and erythropoiesis.
The Mayir Index Approach:
• Eliminates Hb – removes variability due to age, sex, pregnancy, and pre‑analytical factors.
• Integrates MCV, RBC, and RDW – captures both microcytosis and anisocytosis.
• Dynamic adjustment – tailored to age, sex, pregnancy, and ethnicity using global reference data.
• Confirmatory test integration – refines prediction using HbA2, ferritin, iron/TIBC, and HbF.
• Weighted final impression – transparent probabilistic output for each diagnostic category.
Integrated Algorithm 6‑Step Protocol
Step 1 – Calculation: Mayir Index computed from (MCV, RBC, RDW) – formula withheld for intellectual property protection.
Step 2 – Dynamic Cutoff Selection: Based on age, sex, pregnancy, and ethnicity (gray zone = cutoff ± 10).
Disclaimer: This tool is a research‑based decision support system providing probabilistic, supportive interpretations. It does not replace clinical judgment or laboratory confirmation. All results must be correlated with the patient’s full clinical history, physical examination, and additional laboratory findings. The final diagnosis and treatment decisions rest solely with the attending physician.